Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease.
Juzenas S, Hübenthal M, Lindqvist CM, Kruse R, Steiert TA, Degenhardt F, Schulte D, Nikolaus S, Zeissig S, Bergemalm D, Almer S, Hjortswang H, Bresso F; SIC IBD Working Group; Strüning N, Kupcinskas J, Keller A, Lieb W, Rosenstiel P, Schreiber S, D'Amato M, Halfvarson J, Hemmrich-Stanisak G, Franke A. Juzenas S, et al. Among authors: bergemalm d, d amato m. J Crohns Colitis. 2022 Aug 4;16(7):1097-1109. doi: 10.1093/ecco-jcc/jjac003. J Crohns Colitis. 2022. PMID: 35022690 Free PMC article.
Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).
Eriksson C, Marsal J, Bergemalm D, Vigren L, Björk J, Eberhardson M, Karling P, Söderman C; SWIBREG Vedolizumab Study Group; Myrelid P, Cao Y, Sjöberg D, Thörn M, Karlén P, Hertervig E, Strid H, Ludvigsson JF, Almer S, Halfvarson J. Eriksson C, et al. Among authors: bergemalm d. Scand J Gastroenterol. 2017 Jun-Jul;52(6-7):722-729. doi: 10.1080/00365521.2017.1304987. Epub 2017 Mar 31. Scand J Gastroenterol. 2017. PMID: 28362144
Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study.
Chetcuti Zammit S, Ellul P, Girardin G, Valpiani D, Nielsen KR, Olsen J, Goldis A, Lazar D, Shonová O, Nováková M, Sebastian S, Whitehead E, Carmona A, Martinez-Cadilla J, Dahlerup JF, Kievit ALH, Thorsgaard N, Katsanos KH, Christodoulou DK, Magro F, Salupere R, Pedersen N, Kjeldsen J, Carlsen K, Ioannis K, Bergemalm D, Halfvarson J, Duricova D, Bortlik M, Collin P, Oksanen P, Kiudelis G, Kupcinskas L, Kudsk K, Andersen V, O'Morain C, Bailey Y, Doron S, Shmuel O, Almer S, Arebi N, Misra R, Čuković-Čavka S, Brinar M, Munkholm P, Vegh Z, Burisch J. Chetcuti Zammit S, et al. Among authors: bergemalm d. Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1297-1303. doi: 10.1097/MEG.0000000000001238. Eur J Gastroenterol Hepatol. 2018. PMID: 30134383
Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel Disease.
Kalla R, Adams AT, Ventham NT, Kennedy NA, White R, Clarke C, Ivens A, Bergemalm D, Vatn S, Lopez-Jimena B; IBD Character Consortium; Ricanek P, Vatn MH, Söderholm JD, Gomollón F, Nowak JK, Jahnsen J, Halfvarson J, McTaggart S, Ho GT, Buck A, Satsangi J. Kalla R, et al. Among authors: bergemalm d. J Crohns Colitis. 2020 Dec 2;14(12):1724-1733. doi: 10.1093/ecco-jcc/jjaa134. J Crohns Colitis. 2020. PMID: 32598439 Free article.
Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character).
Vatn S, Carstens A, Kristoffersen AB, Bergemalm D, Casén C, Moen AEF, Tannaes TM, Lindstrøm J, Detlie TE, Olbjørn C, Lindquist CM, Söderholm JD, Gomollón F, Kalla R, Satsangi J, Vatn MH, Jahnsen J, Halfvarson J, Ricanek P; IBD-Character Consortium. Vatn S, et al. Among authors: bergemalm d. Scand J Gastroenterol. 2020 Oct;55(10):1146-1156. doi: 10.1080/00365521.2020.1803396. Epub 2020 Aug 11. Scand J Gastroenterol. 2020. PMID: 32780604
Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.
Kalla R, Adams AT, Bergemalm D, Vatn S, Kennedy NA, Ricanek P, Lindstrom J, Ocklind A, Hjelm F, Ventham NT, Ho GT, Petren C, Repsilber D, Söderholm J, Pierik M, D'Amato M, Gomollón F, Olbjorn C, Jahnsen J, Vatn MH, Halfvarson J, Satsangi J. Kalla R, et al. Among authors: bergemalm d, d amato m. J Crohns Colitis. 2021 May 4;15(5):699-708. doi: 10.1093/ecco-jcc/jjaa230. J Crohns Colitis. 2021. PMID: 33201212 Free PMC article.
37 results